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The marked heterogeneity between individuals diagnosed as experiencing schizophrenia 
has troubled nosologists since the very coining of the term. Catalysed by Crow’s (1980) 
hypothesis of independent ‘positive’ and ‘negative’ syndromes, which led to substantial 
breakthroughs in our comprehension of schizophrenia, the last two decades have seen a 
resurgence of interest in the characterisation of symptom dimensions to resolve the issue 
of heterogeneity. A three-dimensional model, comprising ‘psychotic’, ‘negative’ and 
‘disorganised’ syndromes has received considerable research attention and has been 
proposed for inclusion in the Diagnostic and Statistical Manual of Mental Disorders. 
Similarly, a five-dimensional model, adding syndromes of ‘affective disturbance’ and 
‘excitement’, has also attracted an increasing profile of literature. Mounting evidence 
suggests, however, that these models do not adequately reflect the diversity of symptoms 
seen among those with a diagnosis of schizophrenia, and that they may emerge as an 
artefact of lossy factor-analytic techniques applied to measurement models biased or 
inadequate in their coverage of symptoms. To overcome such limitations, in the present 
study one hundred in- and out- patients diagnosed with schizophrenia were assessed for 
symptoms using a comprehensive series of assessment scales. Additionally, participants 
completed a battery of neuropsychological tests tapping five aspects of attention, and 
smooth pursuit eye tracking was also recorded. Using cluster analyses to examine 
correlations between symptoms, eleven groups of symptoms were identified: ‘hostility’, 
‘conceptual disorganisation’, ‘bizarre behaviour’, ‘grandiosity’, ‘auditory hallucinations’, 
‘loss of boundary delusions’, ‘paranoia’, ‘anxious intropunitiveness’, ‘cognitive 
dysfunction’, ‘negative signs’ and ‘social dysfunctions’. All groupings were internally 
consistent, largely independent of others, and supported by other symptom models 
 iv
proposed in the literature. Several of the symptom groupings were validated by 
demonstration of independent relationships with neuropsychological variables or aspects 
of eye movements, and the more complex symptom model was equivalent or superior in 
the prediction of neuropsychological performance than the three- and five- factor 
symptom models. 
 
Implicit in dimensional approaches to conceptualising schizophrenia is the notion that 
the identified groupings may reflect the functioning of distinct brain systems. This thesis 
has demonstrated that the ‘syndromes’ defined by the three- and five- dimensional 
models of schizophrenia are actually heterogeneous groupings of poorly correlated 
symptoms. This, in turn, obscures the relationships between symptoms and underlying 
pathology. Dimensional approaches to psychopathology hold great promise for 
unravelling the nature of psychosis. However, the existing facile descriptions may actively 
constrain the potential for research progress. The rigorously developed description of 
symptomatology presented here represents a compact and useful representation of the 
spectrum of symptoms experienced in schizophrenia, and has demonstrated an 
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